Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Some peripheral reading for those interested - If there is a deal to be done and it is EL there is still a potential for some success according to evaluation of them as a company and they are still good R & D spenders. Conversely, the research commented on in the attached article suggests success can also be achieved without big pharma. GLA
https://www.fiercepharma.com/marketing/eli-lilly-retakes-innovation-crown-while-bms-rates-most-inventive-pharma-annual-study
I have bought and sell before covid . At first they and some RNS on IP patents from US and from EU .at that time share as normal but not a lot . Only when they start covid project research and all rise and i bought in . We know value it is when they can do something useful with covid and other project. What i dont think right why did they just do only one project and moving it to state can getting it out quick.they are very small company cannot do all projects at the same time . From last year all project not finishe yes and then this year. News CBR come out then CART too. While CDX and co op with J&J then other research bring nothing until now.
How can they do finish one really project and bring it out instead doing many just start a new project and leave it for a while?
We value science they do the job and we believe what they are doing that is why we invested but it should show time frame how progress what is whoing on and update so we know which state the research is going on. The slowly update and new project research get out to make thing mess now with so many thing .
If they can announce something get out or result research it should rise share but we don't know yes when.
Stu...sources are people I talk to about my investments and some who have been re invested in Hemo as long as I have been / longer. I don't accept everything I'm told - it's a personal interpretation I take from the bits I hear...that's why I say it's a suggestion and that there's no proof of that.
Tuan - if you go back to the posts last year (not suggesting that's worth spending time doing!) I was cynical about the COVID price uplift. My view was the valuation rocketed because Vlad had put a sign on one of the offices saying "COVID Project Warroom"...or something like that. The SP rise from my perspective was almost definitely due to COVID....but I'll take it!
I wouldn't say I was sad tuan. I am of course disappointed. I only invested what I could afford to and it was to achieve something which I have always wanted to do but I will survive without it or I can wait for another 7 years. I have a diversified portfolio so it's not all bad news. I have only been investing for 3 years and I'm learning all the time. I do feel like a made a big error on this share and I should have seen the red flags earlier, so I'm trying to find a way to understand the situation and determine how redeemable it is.
I have extract feeling from the pass when Hemo announced in breakthrough research on covid research and source money put on plus the speed on trial human mice to bring out any positive faster on treament. That outline a year ago the same now and after waiting that all time we need to waiting more time . There are three projects they need update but. Hopefully only CAR T is real change game now . All other dont know yes when they have said any else .
Investment on research and they outline on the road people can see so at the moment many have down 50 % plus. They cant sell it and go so only wait but they are just so sad to speak out what they think why
Tuan, the work hemo is doing takes time because it's a life saver and you just cannot rush with that until it is proven safe without side effects. Once this is achieved, don't think that sp will rise by 1 or 2p. It will be a massive sp rerate so you need patience in this type of stock. If you think that I will make some money and leave then I am afraid, you have got it wrong.
Vaga, thanks for the apology.
They are not past facts though. They are current facts. I honestly don't believe my posts will have any impact on the SP of Hemo. There are many, many other more significant factors which do impact the SP. If my posts make someone go and do some more research before investing and making up their own minds, what's the issue?.. if they decide just not to invest based on what a stranger on the internet says, then that's not going to be a very successful investment strategy for them in the long run.
At the moments all people bought share at 8 or 10 have been trapped in here for some more time and they hope will turn around for why they think share not as it should be. There is no good to see losing money on paper and sit on there so people just speak out why think go on that way. Share is up and down with the new . Good new share up 10 bags and people are happy and again losing money Make people are very sad.
Ssccss, I do apologise for specifically mentioning you and tuan, but the past facts which are detrimonial to the sp isn't helping the present situation which one has to keep in mind while posting. How would a new potential investor feel reading these posts while he is researching? You may be putting him away just because you are down heavily. Whereas it would have been a nice entry point for him.
Ssccss, we are in that waiting for (hopefully) good period phase .
We've just had some bad news and the cranks pray on the weak and amuse others by spouting bull.
All the news is already out there and Vlad outlined in his latest interview what we can expect in the future.
We all have the choice as to whether wr Hhold or sell, but we should do so because we made an informed choice and not because some Wolf of Wall Street wannabe said so.
Good luck all holders!
The sad true now weknowthere will more share from mint get out untill 9 millions pay off . We can wait if share not up and no more share dilution but we are in situation when when will add over time until good new that is real trouble. Nobidy know when they can bring anything out after 3 years research and at the state now just moving to trial .the time from phase1 to phase3 years and cost a lot then if successful out come that is all we hope for.that is only hope but there is no guarantee all the way will smooth as plant.there pharmacy is high rewards and high risk so let face the true before anything else.
Dig,
"the suggestion I heard from a couple of sources were that Globalco is interested in the rest of our product pipeline"
what sources ???
I understand, no one likes bad news. I am not deramping. I am keeping to the facts and what is currently happening. I don't usually post much, although I have been here 2 years. I am posting at the moment as I am trying to gain clarity on the situation and I am paying a lot of attention now as I am nearly 60% down. Like many others, there are decisions to be made, whether to average down and when etc. How to extricate ourselves from this situation. If more people had posted previously to discuss the facts or if those who did had not been demonized, then maybe the situation would be different for some.
Thank you for your honest appraisal Ssccss.
Do you think when Hemo from 1.9 up to 14 from other research or from covid19 rns ? Why it up because people hope Hemo use mice to speed up research to find the way cure covid relate . There are nothing on other Hemo research bring any positive to the share at all until this time . If you can reread all RNS and track the time with covid rns and then compare share price wil will see that.
The deal on CDX last year not really kick share off either. So we can said that covid announcement make share up and from. March last year until now there is no update covid research any than CBR with cancer cell treatment too. Only in papers that all . All breakthrough and 600000 research fund on covid have gone and come back nothing all that in side RNS tou can read it again from feb 2020 to now.
Ssccss - the suggestion I heard from a couple of sources were that Globalco is interested in the rest of our product pipeline. Now the proof in the pudding won't be there for the moment I realise that, but I'm comfortable it means there's value in our IP. The market doesn't think that though it's just reacting to CDX I think. Vlad also did highlight competitors were around....just don't know how around they really are. After 3 or 4 years as an investor, I'm going to be really bummed if someone comes out with a super rat...
Ssccss, we can assume a lot of things and post whatever we like. There are millions of people reading these posts and I don't like people deramping just because they are unhappy cos the sp has tanked. This is serious for anyone who had invested at maybe 10p and they are not going to like to read crap from those who post here just because they have plenty of time at their disposal. Inspite of the cln conversions, there is a lot of buying at this level and that's why the sp is still holding. Do you think anyone would buy when there is so much pain to come? Clearly there is something that we don't know so just have patience...
Not sure why you're putting Ssccss and Tuan in with George. Seems entirely uncalled for.
Vagabond, people are genuinely asking questions as they don't seem to be aware and I am merely responding . Don't shoot the messengers.
The actual positives will only come through rns from the company. Although the negatives comes from ssccss, tuan and george. Decide what you want to hear.
Brsders, I would welcome hearing some actual positives from people. Not just ramping based on have faith and belief.
I think the continued drop is related to the fact Hemo's IP is not worth much currently. Global co have derisked in terms of taking CDX forward. Clinical trials look like they will take longer to happen. No positive news on other products yet. The inflated SP last year from 2 to 9p was due to Covid RNS, no update on that yet. Not much in terms of incoming funding. Mint are cracking on with their own agenda, irrespective of damage done to Hemo. Can't think of anything else right now.
I am just wondering why this is tumbling down.
I have looked at the accounts and RNS and they seem to be in bed with some big players and have enough cash for the next year or so so I cannot see why it has come down so much, seems a bit overdone.
opinions please